News

Medicare to negotiate price of Ozempic, Wegovy weight-loss drugs Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...
Medicare’s prices for the blockbuster weight-loss drugs Ozempic and Wegovy are likely to decline starting in 2027, thanks to their inclusion on a list of medicines whose prices will be ...
A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.
Expanding Medicare to cover weight loss drugs would cost $35 billion over eight years, according to a new report from the Congressional Budget Office (CBO). In its estimates released Tuesday, CBO ...
Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare or Medicaid under a new rule the Biden administration proposed ...
Ozempic Ozempic is a brand name for a drug known as semaglutide, which helps control blood glucose levels. Medicare Part D covers Ozempic, but the drug is not prescribed solely for weight loss.
Medicare covers Wegovy as a treatment to reduce the risk of serious cardiovascular events in people who have overweight or obesity. It does not cover Wegovy for weight loss.
Medicare will seek to negotiate lower list prices for the blockbuster diabetes and weight loss drugs Ozempic and Wegovy and 14 other medications, a cost-saving move that would take effect in 2027.
The Biden administration moved Friday to negotiate the prices Medicare pays for the blockbuster weight-loss drugs Ozempic and Wegovy, medications costing the massive government health program ...
The Biden administration moved Friday to negotiate the prices Medicare pays for the blockbuster weight-loss drugs Ozempic and Wegovy, medications costing the massive government health program ...